Background: There have been few reports regarding long time survival after lung cancer surgery. The influence of age and pulmonary function on long time survival is still not fully discovered. Some reports suggest that hospitals with a high surgical volume have better results. The aim of this study was to evaluate lung cancer surgery performed in a county hospital in terms of 30 days mortality, complications and predictors of long time survival. Methods: All patients operated with non-small cell lung cancer in the period 1993–2006 were reviewed, and 148 patients were included in the study. 30 days mortality and complications were analyzed by univariate analysis. Kaplan Meier plots were performed to display some of the univariate variables. ...
IF 1.804 (2017)International audienceBackground: Nowadays surgery remains the best treatment for loc...
AbstractObjective: The increased operative mortality associated with pneumonectomy has stimulated th...
Lobectomy is the standard curative treatment for non-small cell carcinoma (NSCLC) of the lung. Most ...
Background: There have been few reports regarding long time survival after lung cancer surgery. The ...
Background: Little was known on long term survival, the use of hospital days, symptoms both initiall...
Surgery is the mainstay treatment of non-small-cell lung cancer (NSCLC), but its impact on very-long...
none8noOBJECTIVES: Older lung cancer patients with multiple morbidities are increasingly referred...
AbstractObjective: The purpose of this study was to determine (in survivors of 5 years after resecti...
Introduction: Lobectomy is the standard curative treatment for non-small cell carcinoma (NSCLC) of t...
Background: This study presents a retrospective evaluation of patient, disease, and treatment featur...
Context. There is very little published data for patients who are status-post lobectomy by Video-Ass...
© 2019 Background: An appropriate treatment of older lung cancer patients has become an important is...
ObjectiveFive-year survival after the diagnosis of non–small cell lung cancer is the most common ben...
Purpose: Lung cancer is the leading cause of cancer death worldwide. Although the 5-year survival ra...
IntroductionSurgery is essential to any curative plan for lung cancer, but is associated with a high...
IF 1.804 (2017)International audienceBackground: Nowadays surgery remains the best treatment for loc...
AbstractObjective: The increased operative mortality associated with pneumonectomy has stimulated th...
Lobectomy is the standard curative treatment for non-small cell carcinoma (NSCLC) of the lung. Most ...
Background: There have been few reports regarding long time survival after lung cancer surgery. The ...
Background: Little was known on long term survival, the use of hospital days, symptoms both initiall...
Surgery is the mainstay treatment of non-small-cell lung cancer (NSCLC), but its impact on very-long...
none8noOBJECTIVES: Older lung cancer patients with multiple morbidities are increasingly referred...
AbstractObjective: The purpose of this study was to determine (in survivors of 5 years after resecti...
Introduction: Lobectomy is the standard curative treatment for non-small cell carcinoma (NSCLC) of t...
Background: This study presents a retrospective evaluation of patient, disease, and treatment featur...
Context. There is very little published data for patients who are status-post lobectomy by Video-Ass...
© 2019 Background: An appropriate treatment of older lung cancer patients has become an important is...
ObjectiveFive-year survival after the diagnosis of non–small cell lung cancer is the most common ben...
Purpose: Lung cancer is the leading cause of cancer death worldwide. Although the 5-year survival ra...
IntroductionSurgery is essential to any curative plan for lung cancer, but is associated with a high...
IF 1.804 (2017)International audienceBackground: Nowadays surgery remains the best treatment for loc...
AbstractObjective: The increased operative mortality associated with pneumonectomy has stimulated th...
Lobectomy is the standard curative treatment for non-small cell carcinoma (NSCLC) of the lung. Most ...